Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.830
-0.020 (-0.70%)
At close: Mar 6, 2026, 4:00 PM EST
2.689
-0.142 (-5.00%)
After-hours: Mar 6, 2026, 7:45 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $6.41 million as of March 6, 2026. Its market cap has increased by 256.23% in one year.
Market Cap
6.41M
Enterprise Value
103.70K
1-Year Change
256.23%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $6.41M, a decrease of -81.36%. That is a compound annual growth rate of -26.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.40M | -1.54% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 6.73M |
| Aptevo Therapeutics | 6.72M |
| Theriva Biologics | 6.67M |
| Aspire Biopharma Holdings | 6.63M |
| Creative Medical Technology Holdings | 6.50M |
| XTL Biopharmaceuticals | 6.47M |
| Immuron | 6.46M |
| Aprea Therapeutics | 6.36M |